Association of FXR gene variants with cholelithiasis
Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants,...
Saved in:
Published in | Clinics and research in hepatology and gastroenterology Vol. 39; no. 1; pp. 68 - 79 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
France
Elsevier Masson SAS
01.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population.
Sequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers (n=30) and control subjects (n=16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n=133, gallstone carriers: n=74). For expression analysis, total RNA and protein were isolated from ileal biopsies.
The sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR=4.73, P=0.022) and normal weight subjects (rs11110385: OR=3.67, P=0.027; rs11110386: OR=3.67, P=0.027) applying the 11+12<>22 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11+12<>22: P=0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P=0.042, OSTalpha: P=0.071, FGF19: P=0.011. Increase: LRH1: P=0.044).
Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene. |
---|---|
AbstractList | Summary Background and aim Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population. Methods Sequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers ( n = 30) and control subjects ( n = 16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n = 133, gallstone carriers: n = 74). For expression analysis, total RNA and protein were isolated from ileal biopsies. Results The sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR = 4.73, P = 0.022) and normal weight subjects (rs11110385: OR = 3.67, P = 0.027; rs11110386: OR = 3.67, P = 0.027) applying the 11 + 12 < > 22 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11 + 12 < > 22: P = 0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P = 0.042, OSTalpha: P = 0.071, FGF19: P = 0.011. Increase: LRH1: P = 0.044). Conclusions Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene. Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population.BACKGROUND AND AIMImpairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population.Sequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers (n=30) and control subjects (n=16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n=133, gallstone carriers: n=74). For expression analysis, total RNA and protein were isolated from ileal biopsies.METHODSSequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers (n=30) and control subjects (n=16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n=133, gallstone carriers: n=74). For expression analysis, total RNA and protein were isolated from ileal biopsies.The sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR=4.73, P=0.022) and normal weight subjects (rs11110385: OR=3.67, P=0.027; rs11110386: OR=3.67, P=0.027) applying the 11+1222 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11+1222: P=0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P=0.042, OSTalpha: P=0.071, FGF19: P=0.011. Increase: LRH1: P=0.044).RESULTSThe sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR=4.73, P=0.022) and normal weight subjects (rs11110385: OR=3.67, P=0.027; rs11110386: OR=3.67, P=0.027) applying the 11+1222 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11+1222: P=0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P=0.042, OSTalpha: P=0.071, FGF19: P=0.011. Increase: LRH1: P=0.044).Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene.CONCLUSIONSThree FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene. Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population. Sequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers (n=30) and control subjects (n=16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n=133, gallstone carriers: n=74). For expression analysis, total RNA and protein were isolated from ileal biopsies. The sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR=4.73, P=0.022) and normal weight subjects (rs11110385: OR=3.67, P=0.027; rs11110386: OR=3.67, P=0.027) applying the 11+1222 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11+1222: P=0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P=0.042, OSTalpha: P=0.071, FGF19: P=0.011. Increase: LRH1: P=0.044). Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene. Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a pivotal role in hepatic and intestinal bile acid metabolism. In this explorative study, the FXR gene was investigated to identify gene variants, associated with gallstone formation in a Caucasian population. Sequencing of the FXR gene was conducted in a randomly selected cohort of gallstone carriers (n=30) and control subjects (n=16) from Stuttgart, Germany. Genomic DNA was obtained from blood leukocytes. Genotype frequencies were established in the total cohort (controls: n=133, gallstone carriers: n=74). For expression analysis, total RNA and protein were isolated from ileal biopsies. The sequencing showed the sole appearance of 10 SNPs in gallstone carriers. Further genotype analysis revealed significant gender- and weight-dependent frequency differences of 3 SNPs between gallstone carriers and controls in males (rs35724: OR=4.73, P=0.022) and normal weight subjects (rs11110385: OR=3.67, P=0.027; rs11110386: OR=3.67, P=0.027) applying the 11+12<>22 allele model. Furthermore, rs11110385 carriers showed a significantly decreased FXR protein expression (11+12<>22: P=0.003). Significant mRNA expression differences between lean rs11110385 carriers and non-carriers were observed in FXR target genes (decrease: ILBP: P=0.042, OSTalpha: P=0.071, FGF19: P=0.011. Increase: LRH1: P=0.044). Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners. Thereby the tag SNP rs11110385 seemed to influence the activation of the FXR gene. |
Author | Harsch, Simone Renner, Olga Richter, Dominique Müller, Oliver Stange, Eduard F. Hirobe-Jahn, Satoko |
Author_xml | – sequence: 1 givenname: Satoko surname: Hirobe-Jahn fullname: Hirobe-Jahn, Satoko email: S_HirobeJahn@uni-hohenheim.de organization: Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany – sequence: 2 givenname: Simone surname: Harsch fullname: Harsch, Simone email: Simone.Harsch@ikp-stuttgart.de organization: Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany – sequence: 3 givenname: Olga surname: Renner fullname: Renner, Olga email: Olga.Renner@ikp-stuttgart.de organization: Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany – sequence: 4 givenname: Dominique surname: Richter fullname: Richter, Dominique email: Dominique.Richter@ikp-stuttgart.de organization: Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany – sequence: 5 givenname: Oliver surname: Müller fullname: Müller, Oliver email: Oliver.Mueller@rbk.de organization: Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany – sequence: 6 givenname: Eduard F. surname: Stange fullname: Stange, Eduard F. email: Eduard.Stange@rbk.de organization: Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25242139$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV1L3UAQhhex1I_6D0Ry2ZsTZzabbFKkIFI_QChoC94Nm81E9zQna3dzFP9993jUi4Lt3MxcvO87zDM7YnP0Iwuxj5AjYHU4z-3gxsC5BFQ56BxAbohtKRFmWuHN5tsMuCX2YpxDKlVCrfGj2JKlVBKLZluo4xi9dWZyfsx8n53eXGW3PHL2YIIz4xSzRzfdZfbODzykyZno4ifxoTdD5L2Xvit-nn77cXI-u_x-dnFyfDmzCstp1nLZFABFVze61qZquMLW6qpqy1pVrGXb6rLpje6xBcSuNcZ0TckGddVhIYtd8Xmdex_87yXHiRYuWh4GM7JfRsKqLFA2DeokPXiRLtsFd3Qf3MKEJ3q9NAm-rAU2-BgD92Td9Hz2FIwbCIFWZGlOa7K0IkugKZFNZvWX-TX_P7avaxsnSA-Ow7PIWTP84ieOc78MY-JHSFES0PXqZauPoYKUqeoUcPR-AHXe_Xv_H7z5poY |
CitedBy_id | crossref_primary_10_1097_MOG_0000000000000423 crossref_primary_10_1111_jgh_14700 crossref_primary_10_1016_j_jhep_2020_05_007 crossref_primary_10_1080_17474124_2019_1549988 crossref_primary_10_1159_000371695 crossref_primary_10_12688_f1000research_15505_1 crossref_primary_10_1016_j_bbadis_2021_166133 crossref_primary_10_1002_ptr_7927 crossref_primary_10_1074_jbc_RA119_012272 crossref_primary_10_1136_bmjgast_2017_000178 |
Cites_doi | 10.1038/ng2101 10.1038/labinvest.2010.107 10.2337/db07-1700 10.1002/hep.21847 10.1016/j.bbalip.2009.06.006 10.1016/j.bbadis.2010.11.011 10.1186/1471-2350-12-149 10.1111/j.1572-0241.2007.01430.x 10.1152/ajpgi.00430.2005 10.1074/jbc.M109.083899 10.1186/1471-230X-13-30 10.1371/journal.pone.0007321 10.1111/j.1365-2036.2006.02836.x 10.1194/jlr.M500215-JLR200 10.1016/j.cmet.2009.09.009 10.1016/S0016-5085(03)01053-9 10.1097/00041433-200406000-00007 10.1111/j.1440-1746.2010.06309.x 10.1016/j.cca.2007.06.004 10.1002/hep.26009 10.1210/me.2007-0565 10.1016/j.mce.2012.05.004 10.1038/cr.2008.289 10.1172/JCI115961 10.1194/jlr.M800162-JLR200 10.1046/j.1365-2036.2000.014s2039.x 10.1101/gad.1083503 10.2741/1193 10.1038/nm1138 10.1016/j.jhep.2007.07.027 10.1016/j.dld.2006.02.005 10.1128/MCB.00852-07 10.1172/JCI117072 10.1074/jbc.274.42.29749 10.1002/hep.20654 10.1194/jlr.M700330-JLR200 10.1016/j.cmet.2005.09.001 10.1621/nrs.08005 10.1186/1476-511X-10-118 10.1016/j.jprot.2012.04.036 10.1074/jbc.M207903200 10.1086/500274 10.1055/s-2006-960174 10.1038/ijo.2009.152 10.1074/jbc.M306422200 10.1002/hep.26710 10.1053/j.gastro.2007.05.015 10.1016/j.bbadis.2010.12.021 10.5009/gnl.2012.6.2.172 10.1002/hep.25740 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Masson SAS Elsevier Masson SAS Copyright © 2014 Elsevier Masson SAS. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Masson SAS – notice: Elsevier Masson SAS – notice: Copyright © 2014 Elsevier Masson SAS. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.clinre.2014.07.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2210-741X |
EndPage | 79 |
ExternalDocumentID | 25242139 10_1016_j_clinre_2014_07_002 1_s2_0_S2210740114001648 S2210740114001648 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --M .1- .55 .FO .~1 08J 08T 0R~ 1P~ 1~. 4.4 457 4G. 53G 5VS 7-5 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AATTM AAXKI AAXUO AAYWO ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV EBS EFJIC EFKBS EJD F5P FDB FIRID FNPLU FYGXN GBLVA HZ~ J1W KOM MO0 O-L O9- OAUVE OC. ON0 P-8 P-9 PC. Q38 ROL SDF SEM SES SPCBC SSH SSZ T5K X7M Z5R ~G- AACTN AFKWA AJOXV AMFUW RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c415t-be593003d89787a69e61bc766b5846e72bb759fa7f1b011dbaaad95ea176d1323 |
ISSN | 2210-7401 2210-741X |
IngestDate | Fri Jul 11 08:25:29 EDT 2025 Thu Apr 03 07:03:27 EDT 2025 Tue Jul 01 00:58:37 EDT 2025 Thu Apr 24 23:09:24 EDT 2025 Sun Feb 23 10:19:02 EST 2025 Tue Aug 26 16:39:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | FXR Ostα/β GWAS ABCB4 ABCB11 LRH1 CYP7A1 bp ILBP SNP HWE NTCP ASBT SHP RT-qPCR BMI OR FGF CI CYP7B1 ABCG5/G8 MALDI-TOF MS ADRB3 LD SEM BA single nucleotide polymorphism base pair β3-adrenergic receptor 25-hydroxycholesterol 7-alpha-hydroxylase organic solute transporters α and β odds-ratio fibroblast growth factor ATP-binding cassette sub-family B member 11 matrix-assisted laser desorption/ionization time-of-flight mass spectrometry linkage disequilibrium bile acid body mass index apical sodium bile acid transporter standard error of the mean cholesterol 7-alpha-hydroxylase liver receptor homologue 1 ATP-binding cassette, sub-family B, member 4 Real-Time Quantitative PCR ATP-binding cassette proteins G5/G8 Na+-taurocholate cotransporting polypeptide farnesoid X receptor Hardy-Weinberg equilibrium short heterodimer partner confidence interval genome-wide association studies ileal lipid binding protein |
Language | English |
License | Copyright © 2014 Elsevier Masson SAS. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c415t-be593003d89787a69e61bc766b5846e72bb759fa7f1b011dbaaad95ea176d1323 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25242139 |
PQID | 1653129917 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1653129917 pubmed_primary_25242139 crossref_citationtrail_10_1016_j_clinre_2014_07_002 crossref_primary_10_1016_j_clinre_2014_07_002 elsevier_clinicalkeyesjournals_1_s2_0_S2210740114001648 elsevier_clinicalkey_doi_10_1016_j_clinre_2014_07_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-02-01 |
PublicationDateYYYYMMDD | 2015-02-01 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | France |
PublicationPlace_xml | – name: France |
PublicationTitle | Clinics and research in hepatology and gastroenterology |
PublicationTitleAlternate | Clin Res Hepatol Gastroenterol |
PublicationYear | 2015 |
Publisher | Elsevier Masson SAS |
Publisher_xml | – name: Elsevier Masson SAS |
References | Van Mil, Milona, Dixon, Mullenbach, Geenes, Chambers (bib0175) 2007; 133 Chen, Ma, Dawson, Sinal, Sehayek, Gonzalez (bib0130) 2003; 278 Inagaki, Choi, Moschetta, Peng, Cummins, McDonald (bib0155) 2005; 2 Berrabah, Aumercier, Gheeraert, Dehondt, Bouchaert, Alexandre (bib0215) 2014; 59 Dowling (bib0070) 2000; 14 Suppl. 2 Stinton, Shaffer (bib0185) 2012; 6 Kemper, Xiao, Ponugoti, Miao, Fang, Kanamaluru (bib0220) 2009; 10 Kovacs, Kress, Rocha, Kurtz, Miquel, Nervi (bib0165) 2008; 48 Siddapuram, Mahurkar, Duvvuru, Mitnala, Guduru, Rebala (bib0035) 2010; 25 Wang, Chen, Moore, Huang (bib0145) 2008; 18 Klass, Bührmann, Sauter, Del Puppo, Scheibner, Fuchs (bib0105) 2006; 23 Povel, Boer, Imholz, Dollé, Feskens (bib0255) 2011; 10 Modica, Gadaleta, Moschetta (bib0110) 2010; 8 Zanlungo, Rigotti, Nervi (bib0125) 2004; 15 Marvelle, Lange, Qin, Adair, Mohlke (bib0050) 2008; 57 van den Berg, Dollé, Imholz, van der, van’t Slot, Wijmenga (bib0200) 2009; 33 Dixit, Choudhuri, Mittal (bib0190) 2006; 38 Bergheim, Harsch, Mueller, Schimmel, Fritz, Stange (bib0095) 2006; 47 Stroeve, Brufau, Stellaard, Gonzalez, Staels, Kuipers (bib0235) 2010; 90 Buch, Schafmayer, Völzke, Becker, Franke, von Eller-Eberstein (bib0025) 2007; 39 Renner, Lütjohann, Richter, Strohmeyer, Schimmel, Müller (bib0045) 2013; 13 Kemper (bib0210) 2011; 1812 Renner, Harsch, Strohmeyer, Schimmel, Stange (bib0100) 2008; 49 Tönjes, Wittenburg, Halbritter, Renner, Harsch, Stange (bib0065) 2011; 12 Wang, Liu, Clegg, Portincasa, Wang (bib0180) 2009; 1791 Grober, Zaghini, Fujii, Jones, Kliewer, Willson (bib0135) 1999; 274 Zhang, Yin, Anderson, Ma, Gonzalez, Willson (bib0225) 2010; 285 Lee, Schmidt, Cummins, Choi, Peng, Zhang (bib0245) 2008; 22 Katsika, Grjibovski, Einarsson, Lammert, Lichtenstein, Marschall (bib0005) 2005; 41 Claudel, Zollner, Wagner, Trauner (bib0120) 2011; 1812 Wittenburg, Lyons, Li, Churchill, Carey, Paigen (bib0020) 2003; 125 Kong, Wang, Chiang, Zhang, Klaassen, Guo (bib0250) 2012; 56 von Kampen, Buch, Nothnagel, Azocar, Molina, Brosch (bib0040) 2013; 57 Renner, Harsch, Schaeffeler, Winter, Schwab, Krawczyk (bib0060) 2009; 4 Klass, Lauer, Hay, Kratzer, Fuchs (bib0055) 2007; 102 Richter, Harsch, Strohmeyer, Hirobe-Jahn, Schimmel, Renner (bib0170) 2012; 75 Kern (bib0085) 1994; 93 Berr, Pratschke, Fischer, Paumgartner (bib0090) 1992; 90 Grünhage, Acalovschi, Tirziu, Walier, Wienker, Ciocan (bib0030) 2007; 46 Lew, Zhao, Yu, Huang, De Pedro, Peláez (bib0205) 2004; 279 Matsubara, Li, Gonzalez (bib0115) 2013; 368 Puppala, Dodd, Fowler, Arya, Schneider, Farook (bib0010) 2006; 78 Mataki, Magnier, Houten, Annicotte, Argmann, Thomas (bib0240) 2007; 27 Holt, Luo, Billin, Bisi, McNeill, Kozarsky (bib0150) 2003; 17 Zanlungo, Nervi (bib0080) 2003; 8 Lamont, Carey (bib0075) 1992; 10 Moschetta, Bookout, Mangelsdorf (bib0160) 2004; 10 Wang, Jiang, Fei, Xin, Cai, Jiang (bib0195) 2007; 384 Wittenburg, Lammert (bib0015) 2007; 27 Landrier, Eloranta, Vavricka, Kullak-Ublick (bib0140) 2006; 290 Kim, Ahn, Inagaki, Choi, Ito, Guo (bib0230) 2007; 48 Kern (10.1016/j.clinre.2014.07.002_bib0085) 1994; 93 Klass (10.1016/j.clinre.2014.07.002_bib0055) 2007; 102 Wang (10.1016/j.clinre.2014.07.002_bib0145) 2008; 18 Klass (10.1016/j.clinre.2014.07.002_bib0105) 2006; 23 Zanlungo (10.1016/j.clinre.2014.07.002_bib0125) 2004; 15 Katsika (10.1016/j.clinre.2014.07.002_bib0005) 2005; 41 Landrier (10.1016/j.clinre.2014.07.002_bib0140) 2006; 290 Marvelle (10.1016/j.clinre.2014.07.002_bib0050) 2008; 57 Kovacs (10.1016/j.clinre.2014.07.002_bib0165) 2008; 48 Wang (10.1016/j.clinre.2014.07.002_bib0180) 2009; 1791 Zanlungo (10.1016/j.clinre.2014.07.002_bib0080) 2003; 8 Wittenburg (10.1016/j.clinre.2014.07.002_bib0020) 2003; 125 Grober (10.1016/j.clinre.2014.07.002_bib0135) 1999; 274 Renner (10.1016/j.clinre.2014.07.002_bib0045) 2013; 13 Renner (10.1016/j.clinre.2014.07.002_bib0060) 2009; 4 Claudel (10.1016/j.clinre.2014.07.002_bib0120) 2011; 1812 Wittenburg (10.1016/j.clinre.2014.07.002_bib0015) 2007; 27 Mataki (10.1016/j.clinre.2014.07.002_bib0240) 2007; 27 Kemper (10.1016/j.clinre.2014.07.002_bib0210) 2011; 1812 von Kampen (10.1016/j.clinre.2014.07.002_bib0040) 2013; 57 Dixit (10.1016/j.clinre.2014.07.002_bib0190) 2006; 38 Moschetta (10.1016/j.clinre.2014.07.002_bib0160) 2004; 10 van den Berg (10.1016/j.clinre.2014.07.002_bib0200) 2009; 33 Zhang (10.1016/j.clinre.2014.07.002_bib0225) 2010; 285 Wang (10.1016/j.clinre.2014.07.002_bib0195) 2007; 384 Modica (10.1016/j.clinre.2014.07.002_bib0110) 2010; 8 Inagaki (10.1016/j.clinre.2014.07.002_bib0155) 2005; 2 Kim (10.1016/j.clinre.2014.07.002_bib0230) 2007; 48 Povel (10.1016/j.clinre.2014.07.002_bib0255) 2011; 10 Siddapuram (10.1016/j.clinre.2014.07.002_bib0035) 2010; 25 Tönjes (10.1016/j.clinre.2014.07.002_bib0065) 2011; 12 Kemper (10.1016/j.clinre.2014.07.002_bib0220) 2009; 10 Stinton (10.1016/j.clinre.2014.07.002_bib0185) 2012; 6 Buch (10.1016/j.clinre.2014.07.002_bib0025) 2007; 39 Dowling (10.1016/j.clinre.2014.07.002_bib0070) 2000; 14 Suppl. 2 Berr (10.1016/j.clinre.2014.07.002_bib0090) 1992; 90 Grünhage (10.1016/j.clinre.2014.07.002_bib0030) 2007; 46 Bergheim (10.1016/j.clinre.2014.07.002_bib0095) 2006; 47 Matsubara (10.1016/j.clinre.2014.07.002_bib0115) 2013; 368 Richter (10.1016/j.clinre.2014.07.002_bib0170) 2012; 75 Renner (10.1016/j.clinre.2014.07.002_bib0100) 2008; 49 Berrabah (10.1016/j.clinre.2014.07.002_bib0215) 2014; 59 Holt (10.1016/j.clinre.2014.07.002_bib0150) 2003; 17 Van Mil (10.1016/j.clinre.2014.07.002_bib0175) 2007; 133 Chen (10.1016/j.clinre.2014.07.002_bib0130) 2003; 278 Puppala (10.1016/j.clinre.2014.07.002_bib0010) 2006; 78 Lew (10.1016/j.clinre.2014.07.002_bib0205) 2004; 279 Kong (10.1016/j.clinre.2014.07.002_bib0250) 2012; 56 Lamont (10.1016/j.clinre.2014.07.002_bib0075) 1992; 10 Stroeve (10.1016/j.clinre.2014.07.002_bib0235) 2010; 90 Lee (10.1016/j.clinre.2014.07.002_bib0245) 2008; 22 |
References_xml | – volume: 90 start-page: 1457 year: 2010 end-page: 1467 ident: bib0235 article-title: Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice publication-title: Lab Invest – volume: 14 Suppl. 2 start-page: 39 year: 2000 end-page: 47 ident: bib0070 article-title: Review: pathogenesis of gallstones publication-title: Aliment Pharmacol Ther – volume: 57 start-page: 1987 year: 2008 end-page: 1991 ident: bib0050 article-title: Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort publication-title: Diabetes – volume: 93 start-page: 1186 year: 1994 end-page: 1194 ident: bib0085 article-title: Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones publication-title: J Clin Invest – volume: 6 start-page: 172 year: 2012 end-page: 187 ident: bib0185 article-title: Epidemiology of gallbladder disease: cholelithiasis and cancer publication-title: Gut Liver – volume: 46 start-page: 793 year: 2007 end-page: 801 ident: bib0030 article-title: Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol publication-title: Hepatology – volume: 278 start-page: 19909 year: 2003 end-page: 19916 ident: bib0130 article-title: Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter publication-title: J Biol Chem – volume: 41 start-page: 1138 year: 2005 end-page: 1143 ident: bib0005 article-title: Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs publication-title: Hepatology – volume: 8 start-page: s1166 year: 2003 end-page: s1174 ident: bib0080 article-title: The molecular and metabolic basis of biliary cholesterol secretion and gallstone disease publication-title: Front Biosci – volume: 15 start-page: 279 year: 2004 end-page: 286 ident: bib0125 article-title: Hepatic cholesterol transport from plasma into bile: implications for gallstone disease publication-title: Curr Opin Lipidol – volume: 384 start-page: 80 year: 2007 end-page: 85 ident: bib0195 article-title: ATP binding cassette G8 T400 publication-title: Clin Chim Acta – volume: 8 start-page: e005 year: 2010 ident: bib0110 article-title: Deciphering the nuclear bile acid receptor FXR paradigm publication-title: Nucl Recept Signal – volume: 12 start-page: 149 year: 2011 ident: bib0065 article-title: Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts publication-title: BMC Med Genet – volume: 48 start-page: 116 year: 2008 end-page: 124 ident: bib0165 article-title: Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans publication-title: J Hepatol – volume: 48 start-page: 2664 year: 2007 end-page: 2672 ident: bib0230 article-title: Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine publication-title: J Lipid Res – volume: 285 start-page: 3035 year: 2010 end-page: 3043 ident: bib0225 article-title: Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia publication-title: J Biol Chem – volume: 279 start-page: 8856 year: 2004 end-page: 8861 ident: bib0205 article-title: The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion publication-title: J Biol Chem – volume: 57 start-page: 2407 year: 2013 end-page: 2417 ident: bib0040 article-title: Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus publication-title: Hepatology – volume: 17 start-page: 1581 year: 2003 end-page: 1591 ident: bib0150 article-title: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis publication-title: Genes Dev – volume: 10 start-page: 118 year: 2011 ident: bib0255 article-title: Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome publication-title: Lipids Health Dis – volume: 125 start-page: 868 year: 2003 end-page: 881 ident: bib0020 article-title: FXR ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice publication-title: Gastroenterology – volume: 78 start-page: 377 year: 2006 end-page: 392 ident: bib0010 article-title: A genome wide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans publication-title: Am J Hum Genet – volume: 75 start-page: 3386 year: 2012 end-page: 3399 ident: bib0170 article-title: MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha publication-title: J Proteomics – volume: 23 start-page: 895 year: 2006 end-page: 905 ident: bib0105 article-title: Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects publication-title: Aliment Pharmacol Ther – volume: 10 start-page: 392 year: 2009 end-page: 404 ident: bib0220 article-title: FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states publication-title: Cell Metab – volume: 39 start-page: 995 year: 2007 end-page: 999 ident: bib0025 article-title: A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease publication-title: Nat Genet – volume: 49 start-page: 2045 year: 2008 end-page: 2054 ident: bib0100 article-title: Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease publication-title: J Lipid Res – volume: 56 start-page: 1034 year: 2012 end-page: 1043 ident: bib0250 article-title: Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice publication-title: Hepatology – volume: 25 start-page: 1093 year: 2010 end-page: 1098 ident: bib0035 article-title: Hepatic cholesterol transporter ABCG8 polymorphisms in gallstone disease in an Indian population publication-title: J Gastroenterol Hepatol – volume: 4 start-page: e7321 year: 2009 ident: bib0060 article-title: A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease publication-title: PLoS ONE – volume: 18 start-page: 1087 year: 2008 end-page: 1095 ident: bib0145 article-title: FXR: a metabolic regulator and cell protector publication-title: Cell Res – volume: 33 start-page: 1143 year: 2009 end-page: 1152 ident: bib0200 article-title: Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study publication-title: Int J Obes (Lond) – volume: 102 start-page: 2482 year: 2007 end-page: 2487 ident: bib0055 article-title: Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation publication-title: Am J Gastroenterol – volume: 368 start-page: 17 year: 2013 end-page: 29 ident: bib0115 article-title: FXR signaling in the enterohepatic system publication-title: Mol Cell Endocrinol – volume: 27 start-page: 8330 year: 2007 end-page: 8339 ident: bib0240 article-title: Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1 publication-title: Mol Cell Biol – volume: 13 start-page: 30 year: 2013 ident: bib0045 article-title: Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease publication-title: BMC Gastroenterol – volume: 90 start-page: 859 year: 1992 end-page: 868 ident: bib0090 article-title: Disorders of bile acid metabolism in cholesterol gallstone disease publication-title: J Clin Invest – volume: 10 start-page: 1352 year: 2004 end-page: 1358 ident: bib0160 article-title: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model publication-title: Nat Med – volume: 133 start-page: 507 year: 2007 end-page: 516 ident: bib0175 article-title: Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy publication-title: Gastroenterology – volume: 1812 start-page: 842 year: 2011 end-page: 850 ident: bib0210 article-title: Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications publication-title: Biochim Biophys Acta – volume: 1791 start-page: 1037 year: 2009 end-page: 1047 ident: bib0180 article-title: New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation publication-title: Biochim Biophys Acta – volume: 27 start-page: 109 year: 2007 end-page: 121 ident: bib0015 article-title: Genetic predisposition to gallbladder stones publication-title: Semin Liver Dis – volume: 22 start-page: 1345 year: 2008 end-page: 1356 ident: bib0245 article-title: Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis publication-title: Mol Endocrinol – volume: 10 start-page: 165 year: 1992 end-page: 191 ident: bib0075 article-title: Cholesterol gallstone formation. 2. Pathobiology and pathomechanics publication-title: Prog Liver Dis – volume: 59 start-page: 2022 year: 2014 end-page: 2033 ident: bib0215 article-title: Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR) publication-title: Hepatology – volume: 47 start-page: 42 year: 2006 end-page: 50 ident: bib0095 article-title: Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers publication-title: J Lipid Res – volume: 290 start-page: G476 year: 2006 end-page: G485 ident: bib0140 article-title: The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 1812 start-page: 867 year: 2011 end-page: 878 ident: bib0120 article-title: Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease publication-title: Biochim Biophys Acta – volume: 274 start-page: 29749 year: 1999 end-page: 29754 ident: bib0135 article-title: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer publication-title: J Biol Chem – volume: 38 start-page: 397 year: 2006 end-page: 403 ident: bib0190 article-title: Association of APOE-C1 gene cluster polymorphisms with gallstone disease publication-title: Dig Liver Dis – volume: 2 start-page: 217 year: 2005 end-page: 225 ident: bib0155 article-title: Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis publication-title: Cell Metab – volume: 39 start-page: 995 issue: 8 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0025 article-title: A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease publication-title: Nat Genet doi: 10.1038/ng2101 – volume: 90 start-page: 1457 issue: 10 year: 2010 ident: 10.1016/j.clinre.2014.07.002_bib0235 article-title: Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice publication-title: Lab Invest doi: 10.1038/labinvest.2010.107 – volume: 57 start-page: 1987 issue: 7 year: 2008 ident: 10.1016/j.clinre.2014.07.002_bib0050 article-title: Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort publication-title: Diabetes doi: 10.2337/db07-1700 – volume: 46 start-page: 793 issue: 3 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0030 article-title: Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol publication-title: Hepatology doi: 10.1002/hep.21847 – volume: 1791 start-page: 1037 issue: 11 year: 2009 ident: 10.1016/j.clinre.2014.07.002_bib0180 article-title: New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation publication-title: Biochim Biophys Acta doi: 10.1016/j.bbalip.2009.06.006 – volume: 1812 start-page: 842 issue: 8 year: 2011 ident: 10.1016/j.clinre.2014.07.002_bib0210 article-title: Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2010.11.011 – volume: 12 start-page: 149 year: 2011 ident: 10.1016/j.clinre.2014.07.002_bib0065 article-title: Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts publication-title: BMC Med Genet doi: 10.1186/1471-2350-12-149 – volume: 102 start-page: 2482 issue: 11 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0055 article-title: Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2007.01430.x – volume: 290 start-page: G476 issue: 3 year: 2006 ident: 10.1016/j.clinre.2014.07.002_bib0140 article-title: The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00430.2005 – volume: 285 start-page: 3035 issue: 5 year: 2010 ident: 10.1016/j.clinre.2014.07.002_bib0225 article-title: Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia publication-title: J Biol Chem doi: 10.1074/jbc.M109.083899 – volume: 13 start-page: 30 year: 2013 ident: 10.1016/j.clinre.2014.07.002_bib0045 article-title: Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-13-30 – volume: 4 start-page: e7321 issue: 10 year: 2009 ident: 10.1016/j.clinre.2014.07.002_bib0060 article-title: A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease publication-title: PLoS ONE doi: 10.1371/journal.pone.0007321 – volume: 23 start-page: 895 issue: 7 year: 2006 ident: 10.1016/j.clinre.2014.07.002_bib0105 article-title: Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2006.02836.x – volume: 47 start-page: 42 issue: 1 year: 2006 ident: 10.1016/j.clinre.2014.07.002_bib0095 article-title: Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers publication-title: J Lipid Res doi: 10.1194/jlr.M500215-JLR200 – volume: 10 start-page: 392 issue: 5 year: 2009 ident: 10.1016/j.clinre.2014.07.002_bib0220 article-title: FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states publication-title: Cell Metab doi: 10.1016/j.cmet.2009.09.009 – volume: 125 start-page: 868 issue: 3 year: 2003 ident: 10.1016/j.clinre.2014.07.002_bib0020 article-title: FXR ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice publication-title: Gastroenterology doi: 10.1016/S0016-5085(03)01053-9 – volume: 15 start-page: 279 issue: 3 year: 2004 ident: 10.1016/j.clinre.2014.07.002_bib0125 article-title: Hepatic cholesterol transport from plasma into bile: implications for gallstone disease publication-title: Curr Opin Lipidol doi: 10.1097/00041433-200406000-00007 – volume: 25 start-page: 1093 issue: 6 year: 2010 ident: 10.1016/j.clinre.2014.07.002_bib0035 article-title: Hepatic cholesterol transporter ABCG8 polymorphisms in gallstone disease in an Indian population publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2010.06309.x – volume: 384 start-page: 80 issue: 1–2 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0195 article-title: ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males publication-title: Clin Chim Acta doi: 10.1016/j.cca.2007.06.004 – volume: 57 start-page: 2407 issue: 6 year: 2013 ident: 10.1016/j.clinre.2014.07.002_bib0040 article-title: Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus publication-title: Hepatology doi: 10.1002/hep.26009 – volume: 22 start-page: 1345 issue: 6 year: 2008 ident: 10.1016/j.clinre.2014.07.002_bib0245 article-title: Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis publication-title: Mol Endocrinol doi: 10.1210/me.2007-0565 – volume: 368 start-page: 17 issue: 1–2 year: 2013 ident: 10.1016/j.clinre.2014.07.002_bib0115 article-title: FXR signaling in the enterohepatic system publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2012.05.004 – volume: 18 start-page: 1087 year: 2008 ident: 10.1016/j.clinre.2014.07.002_bib0145 article-title: FXR: a metabolic regulator and cell protector publication-title: Cell Res doi: 10.1038/cr.2008.289 – volume: 90 start-page: 859 issue: 3 year: 1992 ident: 10.1016/j.clinre.2014.07.002_bib0090 article-title: Disorders of bile acid metabolism in cholesterol gallstone disease publication-title: J Clin Invest doi: 10.1172/JCI115961 – volume: 49 start-page: 2045 issue: 9 year: 2008 ident: 10.1016/j.clinre.2014.07.002_bib0100 article-title: Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease publication-title: J Lipid Res doi: 10.1194/jlr.M800162-JLR200 – volume: 14 Suppl. 2 start-page: 39 year: 2000 ident: 10.1016/j.clinre.2014.07.002_bib0070 article-title: Review: pathogenesis of gallstones publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.2000.014s2039.x – volume: 17 start-page: 1581 issue: 13 year: 2003 ident: 10.1016/j.clinre.2014.07.002_bib0150 article-title: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis publication-title: Genes Dev doi: 10.1101/gad.1083503 – volume: 8 start-page: s1166 year: 2003 ident: 10.1016/j.clinre.2014.07.002_bib0080 article-title: The molecular and metabolic basis of biliary cholesterol secretion and gallstone disease publication-title: Front Biosci doi: 10.2741/1193 – volume: 10 start-page: 1352 issue: 12 year: 2004 ident: 10.1016/j.clinre.2014.07.002_bib0160 article-title: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model publication-title: Nat Med doi: 10.1038/nm1138 – volume: 48 start-page: 116 issue: 1 year: 2008 ident: 10.1016/j.clinre.2014.07.002_bib0165 article-title: Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans publication-title: J Hepatol doi: 10.1016/j.jhep.2007.07.027 – volume: 38 start-page: 397 issue: 6 year: 2006 ident: 10.1016/j.clinre.2014.07.002_bib0190 article-title: Association of APOE-C1 gene cluster polymorphisms with gallstone disease publication-title: Dig Liver Dis doi: 10.1016/j.dld.2006.02.005 – volume: 27 start-page: 8330 issue: 23 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0240 article-title: Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1 publication-title: Mol Cell Biol doi: 10.1128/MCB.00852-07 – volume: 93 start-page: 1186 issue: 3 year: 1994 ident: 10.1016/j.clinre.2014.07.002_bib0085 article-title: Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones publication-title: J Clin Invest doi: 10.1172/JCI117072 – volume: 274 start-page: 29749 issue: 42 year: 1999 ident: 10.1016/j.clinre.2014.07.002_bib0135 article-title: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer publication-title: J Biol Chem doi: 10.1074/jbc.274.42.29749 – volume: 41 start-page: 1138 issue: 5 year: 2005 ident: 10.1016/j.clinre.2014.07.002_bib0005 article-title: Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs publication-title: Hepatology doi: 10.1002/hep.20654 – volume: 48 start-page: 2664 issue: 12 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0230 article-title: Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine publication-title: J Lipid Res doi: 10.1194/jlr.M700330-JLR200 – volume: 2 start-page: 217 issue: 4 year: 2005 ident: 10.1016/j.clinre.2014.07.002_bib0155 article-title: Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis publication-title: Cell Metab doi: 10.1016/j.cmet.2005.09.001 – volume: 10 start-page: 165 year: 1992 ident: 10.1016/j.clinre.2014.07.002_bib0075 article-title: Cholesterol gallstone formation. 2. Pathobiology and pathomechanics publication-title: Prog Liver Dis – volume: 8 start-page: e005 year: 2010 ident: 10.1016/j.clinre.2014.07.002_bib0110 article-title: Deciphering the nuclear bile acid receptor FXR paradigm publication-title: Nucl Recept Signal doi: 10.1621/nrs.08005 – volume: 10 start-page: 118 year: 2011 ident: 10.1016/j.clinre.2014.07.002_bib0255 article-title: Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome publication-title: Lipids Health Dis doi: 10.1186/1476-511X-10-118 – volume: 75 start-page: 3386 issue: 12 year: 2012 ident: 10.1016/j.clinre.2014.07.002_bib0170 article-title: MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha publication-title: J Proteomics doi: 10.1016/j.jprot.2012.04.036 – volume: 278 start-page: 19909 issue: 22 year: 2003 ident: 10.1016/j.clinre.2014.07.002_bib0130 article-title: Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter publication-title: J Biol Chem doi: 10.1074/jbc.M207903200 – volume: 78 start-page: 377 issue: 3 year: 2006 ident: 10.1016/j.clinre.2014.07.002_bib0010 article-title: A genome wide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans publication-title: Am J Hum Genet doi: 10.1086/500274 – volume: 27 start-page: 109 issue: 1 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0015 article-title: Genetic predisposition to gallbladder stones publication-title: Semin Liver Dis doi: 10.1055/s-2006-960174 – volume: 33 start-page: 1143 issue: 10 year: 2009 ident: 10.1016/j.clinre.2014.07.002_bib0200 article-title: Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2009.152 – volume: 279 start-page: 8856 issue: 10 year: 2004 ident: 10.1016/j.clinre.2014.07.002_bib0205 article-title: The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion publication-title: J Biol Chem doi: 10.1074/jbc.M306422200 – volume: 59 start-page: 2022 issue: 5 year: 2014 ident: 10.1016/j.clinre.2014.07.002_bib0215 article-title: Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR) publication-title: Hepatology doi: 10.1002/hep.26710 – volume: 133 start-page: 507 issue: 2 year: 2007 ident: 10.1016/j.clinre.2014.07.002_bib0175 article-title: Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.05.015 – volume: 1812 start-page: 867 issue: 8 year: 2011 ident: 10.1016/j.clinre.2014.07.002_bib0120 article-title: Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2010.12.021 – volume: 6 start-page: 172 issue: 2 year: 2012 ident: 10.1016/j.clinre.2014.07.002_bib0185 article-title: Epidemiology of gallbladder disease: cholelithiasis and cancer publication-title: Gut Liver doi: 10.5009/gnl.2012.6.2.172 – volume: 56 start-page: 1034 issue: 3 year: 2012 ident: 10.1016/j.clinre.2014.07.002_bib0250 article-title: Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice publication-title: Hepatology doi: 10.1002/hep.25740 |
SSID | ssj0000450871 |
Score | 2.0926173 |
Snippet | Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X receptor (FXR) plays a... Summary Background and aim Impairment of bile acid homeostasis is the most important risk factor of gallstone disease. Thereby the bile acid sensor farnesoid X... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 68 |
SubjectTerms | Female Gallstones - genetics Gastroenterology and Hepatology Genetic Variation Humans Internal Medicine Male Polymorphism, Single Nucleotide Receptors, Cytoplasmic and Nuclear - genetics |
Title | Association of FXR gene variants with cholelithiasis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2210740114001648 https://www.clinicalkey.es/playcontent/1-s2.0-S2210740114001648 https://www.ncbi.nlm.nih.gov/pubmed/25242139 https://www.proquest.com/docview/1653129917 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdbB2OXse9l64YHuw0Hy5Lt6DjWhlD6AW0CvgnJVpq0JR62u8MO_dv7nmXZCU1pt4sJTl6c6P30vvQ-CPmueRbEOWa2cizJAffa12auMadBC65oHiisHT46jiczfpBGaZ-n21SX1HqY_d1aV_I_XIV7wFeskv0HznZfCjfgNfAXrsBhuD6Kx2tri0bfOD3Ficjmxx9wgFVXuYYCzoC1vViqalmtW6O2Kajt0tx2_WkCIAvQUXXfnOlcVXVZYPPOciMIP1liLZF_oBY2iAo0l0Uv0srKjpk6Azj0h_enxg37Ork673QC1ve3I0L2Cmx3YnPBu4AEjVwOs5NbIXiRPhgqqVUxW-61gtd2MdoAmJWidtDOHeFu4wwXQ6wZLbHFKeVN49Ug7JWZO8A_PpHj2eGhnO6n06fkWQhOBM63GN7QLgIHxmwwajzy7te52somAfDuY-6zXe7zTRobZfqKvGydC--nRcpr8sSs3pDnR236xFvC1wDjFXMPAOMhYDwHGA8B420C5h2ZjfenvyZ-OzbDz8Aaq2GvRYKBsM5HAqSxioWJqc6SONZobJok1DqJxFwlc6pBuudaKZWLyCiaxDllIXtPdlaAi4_EyzN8XzClInA7MyPAWeYqj5nmAcs4GxDmFkRmbU95HG1yJV3y4IW0yyhxGWWAyQ7hgPgd1W_bU-WBz0duraWrFwYNJwEXD9Al2-hM1W7hSlJZhTKQZwgAHE1JedNybjQg3xxLJYhbPENTK1NcA0UMSgtMOJoMyAfL6-4_hBHmVzDx6RHUn8mLfu_skp26vDZfwLyt9dcGpbe5Z6Xh |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+FXR+gene+variants+with+cholelithiasis&rft.jtitle=Clinics+and+research+in+hepatology+and+gastroenterology&rft.au=Hirobe-Jahn%2C+Satoko&rft.au=Harsch%2C+Simone&rft.au=Renner%2C+Olga&rft.au=Richter%2C+Dominique&rft.date=2015-02-01&rft.issn=2210-741X&rft.eissn=2210-741X&rft.volume=39&rft.issue=1&rft.spage=68&rft_id=info:doi/10.1016%2Fj.clinre.2014.07.002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F22107401%2FS2210740115X00027%2Fcov150h.gif |